Suppression of HPV E6 and E7 expression by BAF53 depletion in cervical cancer cells

Biochemical and Biophysical Research Communications

Volumn 412, Issue 2, 2011, Pages 328-333

  Lee, Kiwon ^a   Lee, Ah Young ^a   Kwon, Yunhee Kim ^b   Kwon, Hyockman ^a  

^a Hankuk University of Foreign Studies   (South Korea)

^b Kyung Hee University   (South Korea)

Author keywords

BAF53; Cervical cancer; Chromatin; Human papillomavirus; Integration

Indexed keywords

ACTIN RELATED PROTEIN; BAF53 PROTEIN; LUCIFERASE; PROTEIN E6; PROTEIN E7; PROTEIN P53; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CONTROLLED STUDY; GENE SILENCING; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN SYNTHESIS INHIBITION; SIGNAL TRANSDUCTION; UTERINE CERVIX CARCINOMA;

ACTINS; CHROMOSOMAL PROTEINS, NON-HISTONE; DNA-BINDING PROTEINS; FEMALE; GENE EXPRESSION REGULATION, VIRAL; GENE KNOCKDOWN TECHNIQUES; HELA CELLS; HUMAN PAPILLOMAVIRUS 18; HUMANS; ONCOGENE PROTEINS, VIRAL; PROMOTER REGIONS, GENETIC; RNA INTERFERENCE; TRANSCRIPTION, GENETIC; TRANSCRIPTIONAL ACTIVATION; TUMOR SUPPRESSOR PROTEIN P53; UTERINE CERVICAL NEOPLASMS;

HUMAN PAPILLOMAVIRUS;

EID: 80052035082     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.07.098     Document Type: Article

References (23)

1. Scheffner M., Huibregtse J.M., Vierstra R.D., Howley P.M. The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell 1993, 75:495-505.
2. Goodwin E.C., DiMaio D. Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways. Proc. Natl. Acad. Sci. USA 2000, 97:12513-12518.
3. Munger K., Basile J.R., Duensing S., Eichten A., Gonzalez S.L., Grace M., Zacny V.L. Biological activities and molecular targets of the human papillomavirus E7 oncoprotein. Oncogene 2001, 20:7888-7898.
4. Daniel B., Mukherjee G., Seshadri L., Vallikad E., Krishna S. Changes in the physical state and expression of human papillomavirus type 16 in the progression of cervical intraepithelial neoplasia lesions analysed by PCR. J. Gen. Virol. 1995, 76:2589-2593.
5. Daniel B., Rangarajan A., Mukherjee G., Vallikad E., Krishna S. The link between integration and expression of human papillomavirus type 16 genomes and cellular changes in the evolution of cervical intraepithelial neoplastic lesions. J. Gen. Virol. 1997, 78:1095-1101.
6. Thierry F. Transcriptional regulation of the papillomavirus oncogenes by cellular and viral transcription factors in cervical carcinoma. Virology 2009, 384:375-379.
7. Romanczuk H., Thierry F., Howley P.M. Mutational analysis of cis elements involved in E2 modulation of human papillomavirus type 16 P97 and type 18 P105 promoters. J. Virol. 1990, 64:2849-2859.
8. Corden S.A., Sant-Cassia L.J., Easton A.J., Morris A.G. The integration of HPV-18 DNA in cervical carcinoma. Mol. Pathol. 1999, 52:275-282.
9. Bechtold V., Beard P., Raj K. Human papillomavirus type 16 E2 protein has no effect on transcription from episomal viral DNA. J. Virol. 2003, 77:2021-2028.
10. Ziegert C., Wentzensen N., Vinokurova S., Kisseljov F., Einenkel J., Hoeckel M., von Knebel Doeberitz M. A comprehensive analysis of HPV integration loci in anogenital lesions combining transcript and genome-based amplification techniques. Oncogene 2003, 22:3977-3984.
11. Pett M.R., Herdman M.T., Palmer R.D., Yeo G.S., Shivji M.K., Stanley M.A., Coleman N. Selection of cervical keratinocytes containing integrated HPV16 associates with episome loss and an endogenous antiviral response. Proc. Natl. Acad. Sci. USA 2006, 103:3822-3827.
12. Sung Y.H., Choi E.Y., Kwon H. Identification of a nuclear protein ArpN as a component of human SWI/SNF complex and its selective association with a subset of active genes. Mol. Cells 2001, 11:75-81.
13. Lee K., Kang M.J., Kwon S.J., Kwon Y.K., Kim K.W., Lim J.H., Kwon H. Expansion of chromosome territories with chromatin decompaction in BAF53-depleted interphase cells. Mol. Biol. Cell 2007, 18:4013-4023.
14. Hu Q., Kwon Y.S., Nunez E., Cardamone M.D., Hutt K.R., Ohgi K.A., Garcia-Bassets I., Rose D.W., Glass C.K., Rosenfeld M.G., Fu X.D. Enhancing nuclear receptor-induced transcription requires nuclear motor and LSD1-dependent gene networking in interchromatin granules. Proc. Natl. Acad. Sci. USA 2008, 105:19199-19204.
15. Gottifredi V., Karni-Schmidt O., Shieh S.S., Prives C. p53 down-regulates CHK1 through p21 and the retinoblastoma protein Mol. Cell. Biol. 2001, 21:1066-1076.
16. Ikura T., Ogryzko V.V., Grigoriev M., Groisman R., Wang J., Horikoshi M., Scully R., Qin J., Y Nakatani. Involvement of the TIP60 histone acetylase complex in DNA repair and apoptosis. Cell 2000, 102:463-473.
17. Stunkel W., Huang Z., Tan S.H., O'Connor M.J., Bernard H.U. Nuclear matrix attachment regions of human papillomavirus type 16 repress or activate the E6 promoter, depending on the physical state of the viral DNA. J. Virol. 2000, 74:2489-2501.
18. O'Connor M.J., Stunkel W., Koh C.H., Zimmermann H., Bernard H.U. The differentiation-specific factor CDP/Cut represses transcription and replication of human papillomaviruses through a conserved silencing element. J. Virol. 2000, 74:401-410.
19. Popescu N.C., DiPaolo J.A., Amsbaugh S.C. Integration sites of human papillomavirus 18 DNA sequences on HeLa cell chromosomes. Cytogenet Cell Genet. 1987, 44:58-62.
20. Macville M., Schrock E., Padilla-Nash H., Keck C., Ghadimi B.M., Zimonjic D., Popescu N., Ried T. Comprehensive and definitive molecular cytogenetic characterization of HeLa cells by spectral karyotyping. Cancer Res. 1999, 59:141-150.
21. Thorland E.C., Myers S.L., Gostout B.S., Smith D.I. Common fragile sites are preferential targets for HPV16 integrations in cervical tumors. Oncogene 2003, 22:1225-1237.
22. Sima N., Wang W., Kong D., Deng D., Xu Q., Zhou J., Xu G., Meng L., Lu Y., Wang S., Ma D. RNA interference against HPV16 E7 oncogene leads to viral E6 and E7 suppression in cervical cancer cells and apoptosis via upregulation of rb and p53. Apoptosis 2008, 13:273-281.
23. Gu W., Putral L., Hengst K., Minto K., Saunders N.A., Leggatt G., McMillan N.A. Inhibition of cervical cancer cell growth in vitro and in vivo with lentiviral-vector delivered short hairpin RNA targeting human papillomavirus E6 and E7 oncogenes. Cancer Gene Ther. 2006, 13:1023-1032.